These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 9706050

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Characterization of amorphous API:Polymer mixtures using X-ray powder diffraction.
    Newman A, Engers D, Bates S, Ivanisevic I, Kelly RC, Zografi G.
    J Pharm Sci; 2008 Nov; 97(11):4840-56. PubMed ID: 18351626
    [Abstract] [Full Text] [Related]

  • 3. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture.
    Rumondor AC, Marsac PJ, Stanford LA, Taylor LS.
    Mol Pharm; 2009 Nov; 6(5):1492-505. PubMed ID: 19634917
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions.
    Taylor LS, Zografi G.
    Pharm Res; 1997 Dec; 14(12):1691-8. PubMed ID: 9453055
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Molecular dynamics simulation of amorphous indomethacin-poly(vinylpyrrolidone) glasses: solubility and hydrogen bonding interactions.
    Xiang TX, Anderson BD.
    J Pharm Sci; 2013 Mar; 102(3):876-91. PubMed ID: 23280486
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization.
    Matsumoto T, Zografi G.
    Pharm Res; 1999 Nov; 16(11):1722-8. PubMed ID: 10571278
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
    Caron V, Tajber L, Corrigan OI, Healy AM.
    Mol Pharm; 2011 Apr 04; 8(2):532-42. PubMed ID: 21323367
    [Abstract] [Full Text] [Related]

  • 12. The effects of absorbed water on the properties of amorphous mixtures containing sucrose.
    Shamblin SL, Zografi G.
    Pharm Res; 1999 Jul 04; 16(7):1119-24. PubMed ID: 10450941
    [Abstract] [Full Text] [Related]

  • 13. The effect of low concentrations of molecularly dispersed poly(vinylpyrrolidone) on indomethacin crystallization from the amorphous state.
    Crowley KJ, Zografi G.
    Pharm Res; 2003 Sep 04; 20(9):1417-22. PubMed ID: 14567636
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of temperature and moisture on the miscibility of amorphous dispersions of felodipine and poly(vinyl pyrrolidone).
    Marsac PJ, Rumondor AC, Nivens DE, Kestur US, Stanciu L, Taylor LS.
    J Pharm Sci; 2010 Jan 04; 99(1):169-85. PubMed ID: 19492305
    [Abstract] [Full Text] [Related]

  • 20. Phase behavior of amorphous molecular dispersions I: Determination of the degree and mechanism of solid solubility.
    Vasanthavada M, Tong WQ, Joshi Y, Kislalioglu MS.
    Pharm Res; 2004 Sep 04; 21(9):1598-606. PubMed ID: 15497685
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.